IRIS
LUS, Giacomo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.767
NA - Nord America 5.293
AS - Asia 3.968
SA - Sud America 665
Continente sconosciuto - Info sul continente non disponibili 405
AF - Africa 53
OC - Oceania 5
Totale 20.156
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 6.333
US - Stati Uniti d'America 5.158
SG - Singapore 1.473
IE - Irlanda 956
CN - Cina 858
IT - Italia 634
HK - Hong Kong 574
BR - Brasile 569
VN - Vietnam 514
UA - Ucraina 429
GB - Regno Unito 413
DE - Germania 353
FR - Francia 168
KR - Corea 157
FI - Finlandia 128
IN - India 97
SE - Svezia 95
TR - Turchia 76
GR - Grecia 69
CA - Canada 59
JP - Giappone 55
AR - Argentina 48
MX - Messico 42
BD - Bangladesh 32
BE - Belgio 31
NL - Olanda 30
IQ - Iraq 25
PL - Polonia 23
HU - Ungheria 22
AT - Austria 21
IR - Iran 20
ID - Indonesia 16
EC - Ecuador 13
ES - Italia 13
ZA - Sudafrica 13
PK - Pakistan 12
CZ - Repubblica Ceca 11
MA - Marocco 10
CH - Svizzera 9
CO - Colombia 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
VE - Venezuela 7
EG - Egitto 6
LT - Lituania 6
CL - Cile 5
IL - Israele 5
PH - Filippine 5
RS - Serbia 5
SA - Arabia Saudita 5
UY - Uruguay 5
UZ - Uzbekistan 5
DO - Repubblica Dominicana 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
PY - Paraguay 4
AU - Australia 3
BG - Bulgaria 3
BO - Bolivia 3
ET - Etiopia 3
EU - Europa 3
HN - Honduras 3
JM - Giamaica 3
LB - Libano 3
MY - Malesia 3
NI - Nicaragua 3
PT - Portogallo 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BB - Barbados 2
BY - Bielorussia 2
DZ - Algeria 2
KG - Kirghizistan 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
SV - El Salvador 2
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GA - Gabon 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
KY - Cayman, isole 1
LV - Lettonia 1
MD - Moldavia 1
Totale 19.746
Salva come PNG Salva come JPEG
Città #
Moscow 2.274
Dublin 955
Santa Clara 662
Singapore 627
Jacksonville 597
Chandler 578
Hong Kong 559
San Jose 539
Ashburn 276
Ho Chi Minh City 167
Seoul 154
Beijing 153
Ann Arbor 146
Princeton 144
Hefei 133
Hanoi 114
Roxbury 112
Dallas 107
Naples 101
Medford 99
Bremen 96
Caserta 88
New York 88
The Dalles 70
Boardman 68
Munich 64
Wilmington 59
Los Angeles 57
Woodbridge 57
Cambridge 51
Council Bluffs 51
Bengaluru 50
São Paulo 50
Memphis 39
San Mateo 39
Milan 31
Brussels 27
Da Nang 26
Norwalk 24
Nuremberg 24
Aversa 22
Des Moines 22
Houston 22
Haiphong 21
Rome 21
Amsterdam 20
Helsinki 19
Rio de Janeiro 19
Jinan 18
Toronto 18
Frankfurt am Main 17
Warsaw 17
Chicago 15
Atlanta 14
Belo Horizonte 14
Chennai 14
Dong Ket 14
Nanjing 14
Tianjin 14
Turku 14
Phoenix 13
Stockholm 13
Tokyo 13
Orem 12
San Francisco 12
Guarulhos 11
Ninh Bình 11
Porto Alegre 11
Redwood City 11
Curitiba 10
Falkenstein 10
Luzzano 10
Mexico City 10
Montreal 10
Mountain View 10
Seattle 10
Thái Bình 10
Vienna 10
Baghdad 9
Columbus 9
Düsseldorf 9
Auburn Hills 8
Biên Hòa 8
Boston 8
Brasília 8
Bắc Ninh 8
Can Tho 8
Joinville 8
Miami 8
Philadelphia 8
Phú Nhuận 8
Siano 8
Casablanca 7
Cuiabá 7
Guangzhou 7
London 7
Napoli 7
Taizhou 7
Zhengzhou 7
Ankara 6
Totale 10.272
Salva come PNG Salva come JPEG
Nome #
INSOLITO PNEUMOCEFALO IPERTESO DA OSTEOMA DEL SENO FRONTALE 231
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. 206
Abnormal accumulation of tTGase products in muscle and erythrocytes of chorea-acanthocytosis patients 203
Modifications moleculaires au cours de la regeneration et reinnervation musculaires in vitro 185
A cluster of progranulin C157KfsX97 mutations in Southern Italy: clinical characterization and genetic correlations 178
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate 176
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 166
Chronic HCV infection and neurological and psychiatric disorders: an overview. 165
Biochemical and morphological evidences supporting the hypothesis of a role of TGase in the pathogenesis of chorea acanthocytosis (C-A) 161
Preliminary results of the FASM study, an on-going italian active pharmacovigilance project 160
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. 158
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 157
Synergistic Interplay between Curcumin and Polyphenol-Rich Foods in the Mediterranean Diet: Therapeutic Prospects for Neurofibromatosis 1 Patients 155
Alemtuzumab significantly improves posterior fossa syndrome presented as a relapse of multiple sclerosis 155
Adiponectin profile at baseline is correlated to progression and severity of multiple sclerosis 153
Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease 153
Analisi in istofluorescenza di densità e distribuzione dei recettori per ConA e WGA in corso di rigenerazione e re-innervazione nel muscolo scheletrico di ratto ischemizzato e denervato, reversibilmente o irreversibilmente 152
A new tRNAHis mutation in the mtDNA results in mitochondrial encephalomyopathy by hampering ATP production 150
Biochemical and morphological evidences supporting the hypothesis of a role of Tgase in the pathogeneisi of Chorea-Acanthocytosis 150
Apparently isolated CNS involvement in Erdheim-Chester disease: Case report 149
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. 149
Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis 146
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 146
[Ambulatory monitoring of arterial pressure in the diagnosis and therapeutic evaluation of dysautonomic diseases: observations in a case of Shy-Drager syndrome] 144
A cluster of progranulin C157KfsX97 mutation in southern Italy- clinical characterization and genetic correlations 144
Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis 143
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study 143
[Unusual histo-cytopathologic findings in a familial case of stiff spine syndrome] 142
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 142
Angiogenesis and Multiple Sclerosis Pathogenesis: A Glance at New Pharmaceutical Approaches 141
Rasagiline improves sleep disorders in Parkinson's disease 141
Biochemical and morphological evidences supporting the hypothesis of a role of TGase in the pathogenesis of chorea acanthocytosis (C-A) 140
Cd19 cell count at baseline predicts b cell repopulation at 6 and 12 months in multiple sclerosis patients treated with ocrelizumab 140
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 138
Malattie dei nervi periferici 138
An unusual phenotype of familial motor and sensory neuropathy with morphological features of HMSN1 138
Myopathic changes in neurofibromatosis type 1 138
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 138
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab 136
Myoplasticity and myoregeneration; from molecular aspects to clinical perspectives 135
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 135
39. Density and distribution of ConA and WGA receptors determined by histofluorescence analysis during degeneration, regeneration and reinnervation of the rat skeletal muscle following ischemia and reversible or irreversible denervation. , : , 134
CTG repeat number in the nonaffected allele of myotonic dystrophy patients is not critical for disease expression 133
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 131
Disability assessment using Google Maps 131
Cecità e diplopia come espressione isolata di metastasi mesencefalica:considerazioni neuroradiologiche neurologiche e neurochirurgiche.A proposito di 2 casi 130
Correction to: Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease 130
A real-world study of alemtuzumab in a cohort of Italian patients 130
Signs and symptoms of COVID-19 in patients with multiple sclerosis 129
Therapeutic Plasmapheresis: a revision of literature 128
Unusual manifestation of vertebral osteoid osteoma: case report 128
NEURO-DEGENERAZIONE CON ACCUMULO CEREBRALE DI FERRO TIPO 1 (NIBA TIPO1), UNA NUOVA FAMIGLIA CON MALATTIA DI HALLERVORDEN SPATZ A DECORSO CLINICO PROTRATTO 128
CECITÀ E DIPLOPIA COME ESPRESSIONE ISOLATA DI METASTASI MESENCEFALICHE: CONSIDERAZIONI NEURORADIOLOGICHE, NEUROLOGICHE E NEUROCHIRURGICHE A PROPOSITO DI DUE CASI” 127
Azathioprine and interferon beta(1a) in relapsing-remitting multiple sclerosis patients: increasing efficacy of combined treatment. 125
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting 125
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study 124
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 123
Retrospective epidemiology of Duchenne muscular dystrophy in Molise 123
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. 123
Reperti isto e citopatologici del tutto peculiari riscontrati in un caso familiare di sindrome della spina rigida 122
LA NEUROMIELITE OTTICA È UN’ ASSOCIAZIONE SINDROMICA COMUNE A PATOLOGIE ETEROGENEE 121
C’È UN GUADAGNO DIAGNOSTICO IN RM DELLE SACNSIONI TARDIVE OPO DOSE TRIPLA DI GADOLINIO NELL’IDENTIFICAZIONE DI PLACCHE ATTIVE DI SCLEROSI MULTIPLA? * Risultati preliminari 121
Long-term effects of asymmetrical posture in boxing assessed by baropodometry 121
Clinical and Genetic Heterogeneity in a Large Family with Pseudoxanthoma Elasticum: MTHFR and SERPINE1 Variants as Possible Disease Modifiers in Developing Ischemic Stroke 120
CORRELATI CLINICO-STRUMENTALI IN UN CASO DI CREUTZFELD- JACOB A LUNGA SOPRAVVIVENZA. 119
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 118
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study 118
Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study. 118
Fluctuations of MS births and UV-light exposure. 118
Fingolimod efficacy in multiple sclerosis associated with Sjogren syndrome 118
Adiponectin Alleviates Cell Injury due to Cerebrospinal Fluid from Multiple Sclerosis Patients by Inhibiting Oxidative Stress and Proinflammatory Response 118
Role of Ocrelizumab in modulating gene and microRNA expression in multiple sclerosis 117
La capacità rigenerativa del muscolo scheletrico danneggiato: studio sperimentale 117
Animal model to study factors influencing regeneration and direct innervation or neurotization of skeletal muscle 117
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice. 115
Autoantibodies in multiple sclerosis patients before and during IFN-β1b treatment: Are they correlated with the occurrence of autoimmune diseases? 115
Dalla malattia di Schilder all’adrenoleucodistrofia; una breve storia di un secolo di ricerca neuropatologica clinica esemplare 115
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 115
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 114
Isolated transient blindness and isolated oculomotor nerve palsy secondary to single mesencephalic metastases: report of 2 cases 114
The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders 113
Revelation of a new mitochondrial DNA mutation (G12147A) in a MELAS/MERFF phenotype. 113
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity 113
Treatment withdrawal in relapsing-remitting multiple sclerosis: a retrospective cohort study 112
Migraine as possible red flag of PFO presence in suspected demyelinating disease 112
Are giant axons a pathological marker of charcot-marie-tooth neuropathy type 2E? 111
Histopathological heterogeneity and cytopathological similarity of findings in different muscles of two brothers affected by rigid spine syndrome 110
Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy 109
Progressive rubella panencephalitis. Follow-up EEG study of a case 109
Prognostic indicators in pediatric clinically isolated syndrome 108
A narrative review of genetic and environmental factors and risk for multiple sclerosis. The design of the Italian multicentric PEDIGREE study 107
Dalla malattia di Schilder alla adrenoleucodistrofia: una breve storia di un secolo di ricerca neuropatologica clinica esemplare 107
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests 107
Monitoraggio biologico e sorveglianza sanitaria ai lavoratori esposti a bromuro di metile 106
Quantitative Evaluation of Upright Posture by x-Ray and 3D Stereophotogrammetry with a New Marker Set Protocol in Late Onset Pompe Disease 105
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 105
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study 104
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases 104
Intracranial extension of orbital inflammatory pseudotumor: A case report and literature review 104
Normative values of the brief international cognitive assessment for multiple sclerosis (BICAMS) in an Italian young adolescent population: the influence of age, sex, and education 104
Totale 13.256
Salva come PNG Salva come JPEG
Categoria #
all - tutte 69.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.834
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.015 0 132 10 27 292 9 27 34 37 68 97 282
2022/20232.026 171 36 32 185 240 179 2 134 923 20 60 44
2023/2024731 70 21 48 56 252 60 10 25 6 3 57 123
2024/20252.675 6 45 40 74 399 406 298 201 393 420 235 158
2025/202610.736 323 424 556 524 895 5.915 639 477 379 276 201 127
2026/2027272 83 189 0 0 0 0 0 0 0 0 0 0
Totale 20.156